Christopher Chipman
2022
In 2022, Christopher Chipman earned a total compensation of $467K as Chief Financial Officer at Virpax Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Option Awards | $81,000 |
|---|---|
| Salary | $296,000 |
| Stock Awards | $90,000 |
| Total | $467,000 |
Chipman received $296K in salary, accounting for 63% of the total pay in 2022.
Chipman also received $81K in option awards and $90K in stock awards.
Rankings
In 2022, Christopher Chipman's compensation ranked 4,459th out of 5,756 executives tracked by ExecPay. In other words, Chipman earned more than 22.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,459 out of 5,756 | 23rd |
Division Manufacturing | 2,510 out of 3,133 | 20th |
Major group Chemicals And Allied Products | 1,205 out of 1,419 | 15th |
Industry group Drugs | 1,132 out of 1,320 | 14th |
Industry Pharmaceutical Preparations | 825 out of 966 | 15th |
Source: SEC filing on December 7, 2023.
Chipman's colleagues
We found two more compensation records of executives who worked with Christopher Chipman at Virpax Pharmaceuticals in 2022.